Still car­ry­ing the bud­get axe, Kåre Schultz is wrap­ping up his stint at Te­va, promis­ing to start pay­ing opi­oid ...

3 years ago
People
Pharma

Af­ter sell­ing failed NASH drug to Ipsen, French start­up nabs a liv­er dis­ease play­er in small buy­out

3 years ago
Deals

On heels of Lumakras da­ta drop, new KRAS idea emerges; Bris­tol My­ers, Ab­b­Vie, Ru­bius head­line busy week of ...

3 years ago
Weekly

Mod­er­na CEO looks to Japan for build­ing new vac­cine man­u­fac­tur­ing site

3 years ago
Pharma
Coronavirus

Amerisource­Ber­gen throws down near­ly $1.3B cash for Ger­man life sci­ences com­pa­ny

3 years ago
Deals
Pharma

HHS pro­motes 'up­dat­ed' Covid vac­cines in next phase of 'We Can Do This' ad cam­paign

3 years ago
Pharma
Marketing

Ahead of FDA, EMA gives thumbs-up to As­traZeneca, Sanofi's RSV an­ti­body for in­fants and new­borns

3 years ago
Pharma

New re­port digs in­to top block­busters and their re­liance on patents to block com­pe­ti­tion

3 years ago
Pharma
Law

A month af­ter GSK's win in Zan­tac can­cer case, plain­tiffs file dozens more suits

3 years ago
Law

J&J ex­pands in Ire­land with a $100M+ in­vest­ment for con­tact lens man­u­fac­tur­ing site

3 years ago
Manufacturing

No­vo Nordisk ex­ecs had on­ly one drug on their mind when they came call­ing at For­ma. Here's the in­side sto­ry of their ...

3 years ago
Deals

Along­side promis­ing first HAE da­ta, In­tel­lia posts read­out in Re­gen­eron-part­nered AT­TR pro­gram

3 years ago
R&D

Pal­isade Bio is the lat­est to re­struc­ture, hun­ker­ing down on its lead pro­gram

3 years ago
People
R&D

Scoop: Ab­b­Vie, Bris­tol My­ers bring out the bud­get axe, out­lin­ing plans to lay off more than 350 West Coast em­ploy­ees

3 years ago
People
Pharma

In­tel­lia presents a promis­ing snap­shot of its first da­ta for once-and-done in vi­vo CRISPR treat­ment for HAE

3 years ago
R&D

Catch­ing up with Mer­ck in ad­ju­vant melanoma, Bris­tol My­ers bur­nish­es Op­di­vo pro­file in ear­li­er stages of can­cer

3 years ago
R&D
Pharma

Biden di­rec­tive on screen­ing for­eign in­vest­ments in US biotech not tar­get­ed at Chi­na, ad­min of­fi­cials say

3 years ago
China
Law

That $930M drug Alex­ion bought to pair with Soliris, Ul­tomiris? As­traZeneca says it just aced a PhI­II test

3 years ago
R&D

Scor­pi­on snags a Sanofi vet to lead the way to the clin­ic; All eyes on eli-cel as blue­bird seeks a fi­nance leader — ...

3 years ago
Peer Review

Lancet com­mis­sion sharply cri­tiques WHO and gov­ern­ments over their Covid re­sponse

3 years ago
Coronavirus

Gilead aims to dri­ve health eq­ui­ty through ed­u­ca­tion eq­ui­ty with new $20M fund

3 years ago
Pharma
Marketing

Van­da sues FDA yet again, ac­cus­es fed­er­al agency of de­lay­ing post-CRL hear­ing

3 years ago
FDA+
Law

Illi­nois phar­ma com­pa­ny to pay al­most $8M af­ter sell­ing OTC drugs un­der ob­so­lete pre­scrip­tion-on­ly la­bels

3 years ago
Pharma
Law

Sen­a­tors ques­tion how HHS plans to roll out new drug pric­ing re­forms

3 years ago
Pharma
Law
First page Previous page 455456457458459460461 Next page Last page
A service from the Financial Times